GB/Z 157-2026 Active National standards

GB/Z 157-2026 In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods

GB/Z 157-2026 In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods

Publish Date: 2026-01-28 Implement Date: 1970-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 114
Out of stock

Basic Information

Standard Code: GB/Z 157-2026
Standard Type: National standards
Standard Status: Active
is_force_gb: no
CCS Name: Medical devices
ICS Name: -
Publish Date: 2026-01-28
Implement Date: 1970-01-01
Pages: 44 pages

Scope

This document sets out requirements and recommendations for the design, development, validation, confirmation, and implementation of nucleic acid amplification tests for the detection of SARS-CoV-2. It covers the pre-test, test, and post-test procedures for human specimens.
This document is applicable to medical laboratories. It is also intended for use by in vitro diagnostic developers, manufacturers, and institutions and organizations supporting SARS-CoV-2 research and diagnosis.
This document is not applicable to environmental samples.

Development Information

Word Count: 71 Thousand words Pages: 44 pages

Adopt standards

ISO/TS 5798:2022

Related Standards

Contact Us